Shanghai Allink Biotherapeutics
A clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics.
HQ location
Shanghai, China
Website
Launch date
Enterprise value
$168—252m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $42.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads